Your browser doesn't support javascript.
loading
Adjuvant Systems for vaccines: 13 years of post-licensure experience in diverse populations have progressed the way adjuvanted vaccine safety is investigated and understood.
Laupèze, Béatrice; Hervé, Caroline; Di Pasquale, Alberta; Tavares Da Silva, Fernanda.
  • Laupèze B; GSK, 20 Avenue Fleming, 1300 Wavre, Belgium. Electronic address: beatrice.n.laupeze@gsk.com.
  • Hervé C; GSK, 20 Avenue Fleming, 1300 Wavre, Belgium. Electronic address: caroline.c.herve@gsk.com.
  • Di Pasquale A; GSK, 20 Avenue Fleming, 1300 Wavre, Belgium. Electronic address: alberta.di-pasquale@gsk.com.
  • Tavares Da Silva F; GSK, 20 Avenue Fleming, 1300 Wavre, Belgium. Electronic address: fernanda.tavares@gsk.com.
Vaccine ; 37(38): 5670-5680, 2019 09 10.
Article en En | MEDLINE | ID: mdl-31420171
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas / Adyuvantes Inmunológicos Tipo de estudio: Etiology_studies / Guideline / Screening_studies Límite: Animals / Humans Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas / Adyuvantes Inmunológicos Tipo de estudio: Etiology_studies / Guideline / Screening_studies Límite: Animals / Humans Idioma: En Año: 2019 Tipo del documento: Article